Sepsis — Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status
Citation(s)
Bathala L, Mehndiratta MM, Sharma VK Transcranial doppler: Technique and common findings (Part 1). Ann Indian Acad Neurol. 2013 Apr;16(2):174-9. doi: 10.4103/0972-2327.112460.
Blehar DJ, Glazier S, Gaspari RJ Correlation of corrected flow time in the carotid artery with changes in intravascular volume status. J Crit Care. 2014 Aug;29(4):486-8. doi: 10.1016/j.jcrc.2014.03.025. Epub 2014 Apr 2.
Cooke WH, Ryan KL, Convertino VA Lower body negative pressure as a model to study progression to acute hemorrhagic shock in humans. J Appl Physiol (1985). 2004 Apr;96(4):1249-61. Review.
Lamia B, Ochagavia A, Monnet X, Chemla D, Richard C, Teboul JL Echocardiographic prediction of volume responsiveness in critically ill patients with spontaneously breathing activity. Intensive Care Med. 2007 Jul;33(7):1125-1132. doi: 10.1007/s00134-007-0646-7. Epub 2007 May 17.
Levitov A, Marik PE Echocardiographic assessment of preload responsiveness in critically ill patients. Cardiol Res Pract. 2012;2012:819696. doi: 10.1155/2012/819696. Epub 2011 Sep 12.
Mackenzie DC, Noble VE Assessing volume status and fluid responsiveness in the emergency department. Clin Exp Emerg Med. 2014 Dec 31;1(2):67-77. eCollection 2014 Dec. Review.
Marik PE, Cavallazzi R, Vasu T, Hirani A Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med. 2009 Sep;37(9):2642-7. doi: 10.1097/CCM.0b013e3181a590da. Review.
Marik PE, Levitov A, Young A, Andrews L The use of bioreactance and carotid Doppler to determine volume responsiveness and blood flow redistribution following passive leg raising in hemodynamically unstable patients. Chest. 2013 Feb 1;143(2):364-370. doi: 10.1378/chest.12-1274.
Marik PE Iatrogenic salt water drowning and the hazards of a high central venous pressure. Ann Intensive Care. 2014 Jun 21;4:21. doi: 10.1186/s13613-014-0021-0. eCollection 2014. Review.
Moore CL, Rose GA, Tayal VS, Sullivan DM, Arrowood JA, Kline JA Determination of left ventricular function by emergency physician echocardiography of hypotensive patients. Acad Emerg Med. 2002 Mar;9(3):186-93. Erratum in: Acad Emerg Med 2002 Jun;9(6):642.
Stevens PM, Lamb LE Effects of lower body negative pressure on the cardiovascular system. Am J Cardiol. 1965 Oct;16(4):506-15.
Stolz LA, Mosier JM, Gross AM, Douglas MJ, Blaivas M, Adhikari S Can emergency physicians perform common carotid Doppler flow measurements to assess volume responsiveness? West J Emerg Med. 2015 Mar;16(2):255-9. doi: 10.5811/westjem.2015.1.24301. Epub 2015 Feb 26.
Thomas KN, Lewis NC, Hill BG, Ainslie PN Technical recommendations for the use of carotid duplex ultrasound for the assessment of extracranial blood flow. Am J Physiol Regul Integr Comp Physiol. 2015 Oct;309(7):R707-20. doi: 10.1152/ajpregu.00211.2015. Epub 2015 Jul 8. Review.
Carotid Doppler Ultrasound for the Measurement of Intravascular Volume Status During Lower Body Negative Pressure Simulation
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
